Abstract
Retrobulbar irradiation for Graves' ophthalmopathy is considered as a safe treatment and has recently been recommended as the initial treatment for patients with moderately severe eye problems. However, calculations using risk factors presently known reveal a theoretical risk of radiation-induced cancer of 1.2%. Therefore, the authors suggest that this treatment should be reserved for the elderly patient, for example above the age of 40-50 years.
Original language | English |
---|---|
Pages (from-to) | 69-71 |
Number of pages | 3 |
Journal | Radiotherapy and Oncology |
Volume | 38 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Jan 1996 |